Zobrazeno 1 - 10
of 152
pro vyhledávání: '"Henry C, Fung"'
Autor:
Stefan K. Barta, Tatyana A. Feldman, Jennifer A. DeSimone, Ellen Kim, Karthik Devajaran, Yibin Yang, Henry C. Fung, Tafseer Mahvish, Shazia Nakhoda, Nadia Khan
Publikováno v:
Blood. 140:6543-6544
Autor:
David B. Miklos, Henry C. Fung, Samantha Jaglowski, Lianqing Zheng, Amer Beitinjaneh, Arati V. Rao, Houston Holmes, Max S. Topp, John M. Pagel, Brian T. Hill, Javier Munoz, Roch Houot, Rajul K. Jain, Noel Milpied, Marie José Kersten, Weimin Peng, Caron A. Jacobson, Michael Wang, John M. Rossi, Frederick L. Locke, Patrick M. Reagan, Ian W. Flinn, John M. Timmerman, Peter A. McSweeney, Andre Goy
Publikováno v:
New England journal of medicine, 382(14), 1331-1342. Massachussetts Medical Society
BACKGROUND Patients with relapsed or refractory mantle-cell lymphoma who have disease progression during or after the receipt of Bruton's tyrosine kinase (BTK) inhibitor therapy have a poor prognosis. KTE-X19, an anti-CD19 chimeric antigen receptor (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d56c829bd9f29c06272c5324d0d65d4
https://pure.amc.nl/en/publications/ktex19-car-tcell-therapy-in-relapsed-or-refractory-mantlecell-lymphoma(76a755ff-3b96-4fb9-9a96-4659ea974031).html
https://pure.amc.nl/en/publications/ktex19-car-tcell-therapy-in-relapsed-or-refractory-mantlecell-lymphoma(76a755ff-3b96-4fb9-9a96-4659ea974031).html
Autor:
Patrick Liu, Nicole Lang, Ashutosh Pathak, Ruth Pettengell, Udo Mueller, Henry C. Fung, Andreas Lammerich, Ingo Diel, Anton Buchner, Camille N. Abboud, Hartmut Link
Publikováno v:
Supportive Care in Cancer. 27:2569-2577
Recombinant granulocyte colony-stimulating factors (rG-CSFs), such as filgrastim, are administered to prevent complications in patients receiving chemotherapy. In Europe, a biosimilar to filgrastim, tevagrastim/ratiograstim/biograstim, was approved i
Autor:
Ran Reshef, Olalekan O. Oluwole, John M. Rossi, Remus Vezan, Mauro P. Avanzi, Yin Yang, Wayne R. Godfrey, Vicki Plaks, David G. Maloney, Jennifer Lee, Alison R. Sehgal, Lovely Goyal, Sven de Vos, Caron A. Jacobson, Javier Munoz, Pashna N. Munshi, Ibrahim Yakoub-Agha, Lori A. Leslie, Henry C. Fung, Basem M. William, Julio C. Chavez, Gilles Salles, Sattva S. Neelapu, Carla Casulo, Joseph D. Rosenblatt
Publikováno v:
Transplantation and Cellular Therapy. 27:S67-S68
Autor:
Henry C. Fung, Shalina Joshi, Yuliya Shestovska, Asya Varshavsky-Yanovsky, Rashmi Khanal, Michael J Styler
Publikováno v:
Transplantation and Cellular Therapy. 27:S409-S410
Autor:
James L. Omel, Yubin Kang, Kelly N. Godby, Jason C. Chandler, Leona Holmberg, Michaela Liedtke, Craig C. Hofmeister, Natalie S. Callander, Keith Stockerl-Goldstein, Donna M. Weber, Seema Singhal, Sarah A. Holstein, Ehsan Malek, Adetola A. Kassim, J. Sybil Biermann, Henry C. Fung, Joachim Yahalom, Dorothy A. Shead, Vishala Neppalli, Shaji Kumar, Matthew Faiman, Caitlin Costello, Carol Ann Huff, George Somlo, Djordje Atanackovic, Jorge J. Castillo, Rashmi Kumar, Noopur Raje, Melissa Alsina, Thomas Martin
Publikováno v:
Journal of the National Comprehensive Cancer Network. 16:11-20
The NCCN Guidelines for Multiple Myeloma provide recommendations for diagnosis, evaluation, treatment, including supportive-care, and follow-up for patients with myeloma. These NCCN Guidelines Insights highlight the important updates/changes specific
Autor:
Brian T. Hill, Navneet S. Majhail, Kimberly A. Kasow, Keith Stockerl-Goldstein, Jean A. Yared, Richard F. Olsson, Amer Beitinjaneh, Bronwen E. Shaw, Heather R. Millard, Amelia Langston, Anita D'Souza, Zachariah DeFilipp, Hillard M. Lazarus, Regina M. Myers, Adriana K. Malone, Bipin N. Savani, Mary E. D. Flowers, Minoo Battiwalla, Matthew J. Ehrhardt, Mehdi Hamadani, Baldeep Wirk, Samantha Jaglowski, Robert J. Hayashi, William A. Wood, Anne B. Warwick, Soyoung Kim, Yoshihiro Inamoto, Henry C. Fung, David I. Marks, Andrew Daly, Jana Reynolds, Steven P. Margossian, David Buchbinder, Prakash Satwani
Publikováno v:
Cancer. 124:816-825
BACKGROUND Autologous hematopoietic cell transplantation (auto-HCT) is a standard therapy for relapsed classic Hodgkin lymphoma (cHL) and diffuse large B-cell lymphoma (DLBCL); however, long-term outcomes are not well described. METHODS This study an
Autor:
Yuanyuan Tian, Yanyun Zhang, Min Jin, Anqi Ma, Pan Chen, Ran Reshef, Shan He, Shaoyan Hu, Changhong Li, Hongshuang Yu, Yi Zhang, Qing Tong, Yongnian Liu, Jian Jin, Elizabeth O. Hexner, Yuting Gu, Qingrong Huang, Jiefang Huang, Henry C. Fung
Publikováno v:
Blood. 129:2737-2748
Modulating T-cell alloreactivity has been a main strategy to reduce graft-versus-host disease (GVHD), a life-threatening complication after allogeneic hematopoietic stem-cell transplantation (HSCT). Genetic deletion of T-cell Ezh2, which catalyzes tr
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:S186-S187
Graft versus Host Disease (GvHD) represents one of the major causes of post-Allogeneic Stem Cell transplant (alloSCT) treatment-related morbidity and mortality compromising the benefits associated with alloSCT. Acute GvHD (aGVHD) affects up to 80% of
Autor:
Essel Dulaimi, Hongxing Sun, Lei-Zhen Zheng, Jean Pierre J. Issa, Yongnian Liu, Min Tao, Yi Zhang, Shan He, Henry C. Fung, Jian Wang, Ying Wang, Hanghang Zhang, Lijun Meng, Stefan K. Barta
Integrin αEβ7 (CD103) can interact with E-cadherin and promote T cell retention in epithelial tissue. However, whether the expression of CD103 on chimeric antigen receptor (CAR)-T cells may augment T cell anti-tumor activity remains unknown. Using
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a584c8d8e74e1d45445babf5544c9f7a